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Summar Flow cytometr; using the tumour perfusion probe Hoechst 33342 was employed to examine the
distribution of photosensitisers in tumour cells located at different distances from the blood supply. Two
tumour models. the SCCVII squamous cell carcinoma and FsaR fibrosarcoma growing in C3H'HeN mice.
were used in the experiments. Among the photosensitisers tested. only BPD (benzoporphyrin derivative
monoacid) exhibited uniform distribution in tumour cells irrespective of their distance from the vasculature. In
this repect. 5-aminolaevulinic acid (i.e. its metabolite protoporphyrin IX). di- and tetrasulphonated aluminium
phthalocyanines (AIPcS and AIPcS4). di- and tetrasulphonated tetraphenylporphines (TPPS. and TPPS4).
Photofrin and bacteriochlorophyll-a (i.e. its metabolite bacteriopheophytin-a) followed BPD in decreasing
order in their efficacy of accumulation in tumour cells remote from the blood supply. This photosensitiser
property appeared not to depend on tumour type, tumour size, route of photosensitiser administration. time
after the administration. photosensitiser lipophilicity or on the presence of host cell infiltrate in the tumour.
Following treatment with photodynamic therapy (PDT) in vivo, tumour cells were sorted based on their blood
vessel proximity and their survival was determined by colony formation assay. The data demonstrate that the
direct killing of tumour cells by Photofrin- and AlPcS,-based PDT decreases with increasing distance of the
cells from the blood supply.
The phototoxic effect inflicted on target (e.g. tumour) tissue
by photodynamic therapy (PDT) depends on three main
parameters: photosensitiser concentration, oxygen level and
light dose absorbed by the photosensitiser (Pass, 1993). The
direct killing of tumour cells by the phototoxic effect of PDT
requires adequate photosensitiser concentration in these
target cells. However. even those photosensitisers charac-
terised as good tumour localisers are retained to a large
extent in the acellular tumour structures (Peng et al.. 1990).
Hence. the determination of photosensitiser concentration
per gram of tumour tissue is not sufficient to predict the
potential for direct tumour cell killing. In addition to the
affinity of a photosensitiser for acellular tumour structures,
the abundance of these structures and their composition in
the tumour is an important determinant. The importance of
cellular tissue composition can be illustrated by the example
of the spleen, which is known to contain considerably higher
tissue levels of Photofrin and many other photosensitisers
than a solid tumour (Bellnier et al., 1989). Yet, we have
found that Photofrin levels per individual spleen cell of a
C3H mouse are several times lower than the average level of
this photosensitiser in cells of a tumour growing in the same
animal (M. Korbelik & G. Krosl, manuscript in preparation).
This can be explained by the fact that the spleen contains
many more cells per gram of tissue than the tumour.
Using enzymatic digestion, tumours and other tissues can
be disaggregated into single-cell suspensions. and this allows
the determination of photosensitiser levels per cell. However,
the information on the average photosensitiser cellular level
will probably still be inadequate to predict the direct killing
of tumour cells by PDT. This becomes evident upon the
examination of tumour cell suspensions, which reveals con-
siderable heterogeneity in the cellular photosensitiser content
(Korbelik, 1993). One of the main factors identified to be
responsible for this heterogeneity is the presence of host
immune cell populations infiltrating the tumour. Mac-
rophages are the most prominent population of host cell
infiltrate in many tumours. These cells retain markedly higher
levels of Photofrin and other photosensitisers than the paren-
chymal malignant cells (Korbelik et al., 1991: Korbelik. 1993:
Korbelik & Krosl. 1993).
In our preliminary report (Korbelik & Krosl. 1993). we
identified another factor that may be responsible for the
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heterogeneity of photosensitiser cellular content even within
the malignant cell population. This factor is the non-
uniformity of photosensitiser accumulation in cells located at
different distances from the blood supply, which is examined
in detail in the present report.
In order to address this issue, we have adapted a flow
cytometry technique that was originally developed for study-
ing the radiosensitivity of tumour cells relative to their blood
vessel proximity (Olive et al., 1985; Chaplin et al., 1987). This
technique is based on using the bisbenzimide DNA-binding
fluorescent stain Hoechst 33342 (Hoechst). When admin-
istered intravenously, Hoechst clears rapidly from the circula-
tion and, because of its diffusion/'binding properties. its
accumulation in tumour cells varies with their distance from
the closest blood vessel (Durand et al., 1990). We have used
a dual laser flow cytometry instrument for simultaneous
excitation of Hoechst and the photosensitiser, and for
measurement of their fluorescence in single tumour cells.
Materials and methods
Photosensitisers
Photofrin and BPD (benzoporphyrin derivative monoacid)
were obtained from QuadraLogic Technologies Photothera-
peutics (Vancouver, BC, Canada). Bacteriochlorophyll-a, di-
and tetrasulphonated tetraphenylporphines (TPPS. and
TPPS4) and di- and tetrasulphonated aluminium phthalo-
cyanines (AlPcS2 and AlPcS4) were purchased from Por-
phyrin Products (Logan, UT, USA), while 5-aminolaevulinic
acid (ALA) is produced by Sigma (St Louis. MO, USA).
Photofrin was used as originally prepared in the physio-
logical saline. Phosphate-buffered saline (PBS) was used to
dissolve AlPcS2, AlPcS4., TPPS4 and ALA. The stock solu-
tions of BPD and TPPS2 were prepared in dimethylsulphoxide
and diluted 16 times in PBS immediately before administra-
tion. The stock solution of bacteriochlorophyll-a was first
prepared in Hanks' balanced salt solution (HBSS) containing
10% Tween 80 (Sigma) and then further diluted in HBSS as
described by Henderson et al. (1991).
Tumour models and PDT
The tumours. SCCVII (squamous cell carcinoma) and FsaR
fibrosarcoma. were grown in female C3H HeN mice. Their
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maintenance by biweekly transplantation and the implanta-
tion for the experiments (subcutaneous on the sacral region
on the back of mice) was described previously (Korbelik.
1993). These two tumour models were chosen as represen-
tatives for carcinomas and sarcomas. One of the potentially
relevant parameters in which they differ is the cell size. i.e.
the SCCVII cells are considerably larger. The vascular per-
fusion of SCCVII tumour has been well characterised using
Hoechst 33342 and other fluorescent probes (e.g. Olive et al..
1985: Chaplin et al.. 1987). The tumours used in the
experiments measured 200-300 mg wet weight, except where
noted differently.
A tunable light source with a 1 kW xenon bulb (model
A5000. Photon Technology International) was used for PDT.
The tumours were treated by external irradiation with light
delivered through a liquid light guide (5 mm core diameter.
Oriel Corp.). The light was delivered with an output power
of 41 mW (at 630 ± 10nm) for Photofrin. 32 mW (at
674 ± 10 nm) for AlPcS. and 31 mW (at 690 ± 10 nm) for
BPD. The fluence rate was 45 mW cm-- for Photofrin and
35 mW cm-- for AlPcS. and BPD. All tumours received a
dose of 80 J cm--. which is in the curative range under the
conditions of this study. The light treatment was performed
24 h after the idministration of Photofrin or AlPcS:. or 3 h
after the administration of BPD. All hair in the area of the
light treatment was removed by double shaving at the time of
tumour implantation. The fluorescent probe Hoechst (Sigma)
dissolved in PBS was administered intravenously via the
lateral tail vein at 37.5 mg kg-' 30 min before the light treat-
ment.
Flow cytometrv and sorting
The tumours growing in mice that were administered
different photosensitisers and received Hoechst (37.5 mgkg-.
i.v.) were excised 30 min after the Hoechst injection. After
mincing, the tumours were dissociated into single-cell suspen-
sions using an enzymatic digestion procedure descnrbed pre-
viously (Korbelik, 1993). The cells were resuspended in HBSS
supplemented with 2% fetal bovine serum (FBS, HyClone
Laboratories, Logan, UT. USA) and then analysed by flow
cytometry using a dual-laser instrument FASC 440 (Becton
Dickinson). Hoechst was excited by the UV laser and its
fluorescence was detected through a 449 ± 5 nm bandpass
filter. The 514 nm laser was employed for the excitation of
photosensitisers and the emission of their fluorescence over
615 nm was recorded using a longpass filter. The exception
were the experiments with A1PcS2 and A1PcS4 in which the
photosensitiser was also excited by the UV laser (Korbelik,
1993).
The flow cytometry analysis of tumour cell suspensions
based on Hoechst fluorescence was performed using a tech-
nique developed earlier in this laboratory with the SCCVII
tumour model (Olive et al., 1985). Briefly, the fluorescence
intensity' of Hoechst-stained cells was divided by the forward
light scatter signal for each cell to obtain a measure of
cellular concentration of the dye. The light scatter signals
were also used to exclude cellular debris from the analysis.
Tumour cells were grouped into ten fractions (sort windows)
based on Hoechst concentration. Fraction 10 contained the
10% of cells with the highest value for Hoechst fluorescence
intensity divided by cell size, i.e. the cells closest to the blood
supply. Fraction 9 consisted of the 10% of cells with the next
highest Hoechst concentration, etc. Fraction 1 represented
the 10% of cells with the lowest Hoechst concentration, i.e.
the cells most distant from the blood supply. In this study,
the software program generated the average fluorescence
readouts >610nm per cell for each of the ten fractions.
In some experiments, the FsaR tumour cell suspensions
were also stained with fluorescein isothiocyanate-conjugated
goat anti-mouse IgG (Sigma) before flow cytometry in order
to distinguish the FcR-positive cells (predominantly mac-
rophages) and FcR-negative cells (mostly malignant cells). As
described previously (Korbelik et al., 1991), the antibody was
added to the cell suspension for a brief (2 min) incubation at
37'C. The cells were then washed bv centrifugation and kept
on ice until the flow cytometry analysis. Fluorescein was
excited bv the 488 nm laser and the emission detected using a
530 ± 15 nm bandpass filter. In these experiments, the UV
laser was used to excite both Hoechst and Photofrin.
The data reported are based on the analysis of I0 cells in
each sample. and expressed as the average value per cell
obtained With five or more tumours (except when represen-
tative examples of individual tumours are shown). The values
for photosensitiser fluorescence per cell were given after sub-
tracting the average per cell background red fluorescence for
the individual Hoechst fractions obtained with the tumours
excised from mice not injected with a photosensitiser.
The same flow cytometry technique was used with single-
cell suspensions from the PDT-treated tumours. except that a
known number of cells from Hoechst fractions 1. 4, 7, 9 and
10 was sorted under sterile conditions into the tubes filled
with 4 ml of a medium (Gibco. Burlington. Ontario. Canada)
supplemented with 1000 FBS. The content of the tubes was
transferred into 60 mm plastic Petri dishes (Falcon 3002,
Becton Dickinson) and the tubes were rinsed twice with 1 ml
of the cell growth medium to ascertain that all the cells are
transferred into the Petri dish. The samples in Petri dishes
were left in a carbon dioxide incubator (37°C) in the dark for
10 days to allow colony formation. The colonies were then
stained and counted to calculate the cell survival. The data
presented are based on colony count in the three replicate
Petri dishes (five replicates for the controls) and give average
values for six identically treated tumours.
Results
Hoechst administered intravenouslv to tumour-bearing mice
exhibits a wide range of retention levels in the tumour cells.
Studies published by other investigators (Olive et al.. 1985;
Chaplin et al.. 1987) have suggested that in situ uptake of
Hoechst in the SCCVII tumour depends primarily on cell
location relative to the blood supply. The example of
Hoechst distribution in SCCVII tumour cells obtained by
flow cytometry analysis is shown in Figure la. The cells were
divided into ten fractions according to the Hoechst concen-
tration (fluorescence intensity corrected for the cell size) each
containing 10% of the total population. The cells in fraction
10 showed the highest Hoechst levels, which implies that they
were the closest to the blood suppl., while fraction 1 con-
tained the cells with the lowest Hoechst levels. i.e. those that
were the most distant from the vasculature.
The same type of analysis was performed with another
tumour model, the FsaR fibrosarcoma. with results very
similar to those obtained with the SCCVII tumour. as shown
also in Figure 1a. With both tumours. there was more than a
10-fold difference in Hoechst accumulation between fractions
1 and 10.
An example of the application of using Hoechst as the
tumour perfusion probe for the analysis of the distnrbution of
photosensitisers in tumour cells located at different distances
from the blood supply is shown in Figure lb. The photosen-
sitiser examined was TPPS4, which was administered intra-
venously into the SCCVII tumour-bearing mice 24 h before
tumour excision. As in all the other experiments in this
study, mice received Hoechst (37.5 mg kg-', i.v.) 30 min
before the tumour excision. The distribution of TPPS4 in the
ten Hoechst fractions is shown for five individual tumours.
For comparison, a curve for a tumour not containing TPPS4
is also shown. It can be seen that TPPS4 levels in tumour
cells decrease with the increased distance of these cells from
the nearest blood vessel.
The analysis of TPPS4 distribution in tumour cells relative
to their proximity to the blood supply is also shown in
Figure 2. The data in this figure are based on the average of
values obtained with a group of identically treated tumours
corrected for the background red fluorescence of tumour
cells. A possible influence of two different routes of
photosensitiser administration is also examined. No sig-606 M. KORBELIK & G. KROSL
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Fge 2 The distribution of TPPS4 in SCCVII tumour cells
relative to their proximity to the blood supply. The photosen-
sitiser was administered either intravenously (V) or intra-
peritoneally (A) (25mg kg-') 24h before the tumour excision.
Hoechst was administered and the flow cytometry analysis based
on the ten Hoechst fractions was performed as described in
Figure 1. The data represent the average from five tumours. The
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Fie 1 Representative examples of distribution of Hoechst
33342 concentration in cells of SCCVII and FsaR tumour and
the profiles of cellular levels of TPPS4 in individual tumours in
relation to Hoechst tumour perfusion. a, Tumour-bearing mice
received Hoechst (37.5mgkg-', i.v.) 30min before the tumours
were excised and single-cell suspensions were rendered for flow
cytometry analysis. Based on Hoechst concentration (fluorescence
intensity in arbitrary units, a.u., divided by forward light scatter
signal serving as a measure for cell size) tumour cells were
grouped into ten equal fractions indicative ofcell location relative
to the blood supply. b, In addition to Hoechst, the mice bearing
SCCVII tumour received TPPS4 (25 mg kg-', i.v.) 24 h before the
tumour excision. The photosensitiser fluorescence in the ten
Hoechst fractions is shown for five individual tumours (curves
2-6). Also shown is the red fluorescence in the cells from a
tumour excised from a mouse not injected with TPPS4 (curve 1).
nificant difference between intravenous and intraperitoneal
administration can be detected; in both cases the TPPS4
content in tumour cells decreased constantly with the cell
distance from the blood supply, dropping in fraction 1 to
35-40% of the values measured in fraction 10.
The same type of analysis was applied with other
photosensitisers in this study. The results with di- and
tetrasulphonated derivatives of tetraphenylporphyine and
aluminium phthalocyanine are shown in Figure 3. The data
in this figure are presented as values relative to the photosen-
sitiser level in the cells nearest to the tumour blood vessel
(fraction 10). In arbitrary units of photosensitiser fluore-
scence, the values for fraction 10 obtained with disul-
phonated and tetrasulphonated forms of tetraphenylporphine
were not statistically different (not shown). Di- and tetrasul-
phonated aluminium phthalocyanines also showed very
similar cellular levels. The data in Figure 3 suggest that there
is no significant difference in cellular distribution depending
on the tumour blood supply between disulphonated and
tetrasulphonated forms of either tetraphenylporphine or
aluminium phthalocyanine. However, the aluminium
phthalocyanines showed better diffusion to cells more distant
from the blood supply than the tetraphenylporphines. A
notable decrease in AlPcS2 and AlPcS4 levels can be observed
only in the cells most remote from the vasculature.
The next set of experiments was designed to examine the
factor of time elapsed after the photosensitiser administra-
tion. The first example (Figure 4a) shows the results with a
photosensitiser characterised by relatively slow accumulation
and long retention in tumours. It can be seen that higher
levels of AlPcS2 are accumulated in the tumour cells at 24 h
than at 2 h after the photosensitiser administration. However,
the diffusion profiles of AlPcS2 for these two post-admini-
stration time intervals look very alike. Similar results were
obtained with BPD, a photosensitiser that exhibits much
faster tumour clearance. Its levels in tumour cells were
markedly higher at 4 h than at 24 h post administration, but
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the pattern of BPD distribution between the ten Hoechst
fractions was again very similar (Figure 4b). It can also be
seen that BPD shows a very good accumulation in the
tumour cells farthest from the blood supply.
The photosensitisers shown in Figure 5 are examples of
photosensitiser fluorescence that comes from a metabolite of
Blood vessel
1.2 4
the drug administered to the tumour-bearing animals. The
distribution of protoporphyrin IX, formed from the
administered ALA (Kennedy et al., 1990), was relatively
uniform throughout fractions 10 to 3, with a decrease in the
cellular levels seen only in the two cellular fractions most
remote from the blood supply (Figure 5a). The results were
quite different with bacteriopheophytin-a, the metabolite
formed rapidly after the administration of bacteriochloro-
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Figwe 3 The distribution of di- and tetrasulphonated forms of
tetraphenylporphine and aluminum phthalocyamne in SCCVII
tumour cels relative to their proximity to the blood supply. a,
Mice administered TPPS2 (O) or TPPS, (A) (25mg kg-', i.p.)
24h before tumour excision. b, Mice given AIPcS2 (O) or
AIPcS4 (A) (1Omg kg-', i.v.) 24h before excision. Hoechst was
administered and flow cytometry analysis was performed as des-
cribed in Figure 1. The data are given as values of the ratio to
the photosensitiser fluorescence in the Hoechst fraction 10. The
bars show ± s.d.
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Figwe 4 The distribution of A1PcS2 and BPD in SCCVII
tumour cells relative to their proximity to the blood supply at
different times after the photosensitiser administration. a, AIPcS2
administered at 10 mg kg- ' i.v. either at 2 (0) or 24 h (O) before
tumour excision. b, BPD adinistered at 5 mg kg-', i.v. either at
4 (0) or 24 h (0) before tumour excision. Hoechst was
administered as described in Figure 1. The presentation of the
data based on flow cytometry analysis is the same as in Figure 2.
The bars show ± s.e.
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phyll-a (Henderson et al., 1991). Its levels decreased
markedly in fraction 9, while very little, if any, photosen-
sitiser was detectable in the cells most distant from the
vasculature (Figure 5b).
The analysis of Photofrin distribution in tumour cells
relative to the blood supply is shown in Figures 6 and 7. The
comparison of the results obtained with the two different
tumour types (Figure 6) reveals no significant differences. In
both SCCVII and FsaR tumours, Photofrin exhibited
relatively poor accumulation in cells removed from the blood
supply. The level of this photosensitiser in the cells most
distant from the vasculature was reduced to approximately
one-fifth of the level detected in the cell fraction nearest to
the blood vessel. These data, as well as those shown in the
previous figures, are obtained with the tumours which ranged
between 200 and 300 mg wet weight. A possible role of
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tumour size was also explored. The insert to Figure 6 shows
the representative examples for a 'large' tumour (241 mg wet
weight) and a 'small' tumour (19 mg wet weight). The smaller
tumour exhibited better Photofrin accumulation than the
larger tumour, in accordance with findings reported by other
investigators (Bellnier et al., 1989). However, the distribution
of Photofrin in tumour cells relative to their proximity to the
blood supply was not significantly different between these
two tumours. This may be a reflection of a similar vascular
perfusion of tumours within the size range examined.
Since tumour-associated macrophages (TAMs) have been
shown to accumulate more Photofrin than the malignant
tumour cells (Korbelik et al., 1991; Korbelik, 1993), it was
important to examine the photosensitiser diffusion profiles
separately in these two different tumour cell populations.
Using a technique described previously (Korbelik, 1993), the
FsaR tumour cell suspension was separated into the Fc
receptor-positive cells (predominantly TAMs) and the cells
stained negatively for the Fc receptor (predominantly malig-
nant cells) (Figure 7). Although, as expected, the FcR+
population was characterised by several times higher Photof-
rin levels than the FcR- population, the photosensitiser dist-
ribution in cells relative to their proximity to the blood
supply was, with both these populations, very similar to that
depicted in Figure 6. The inset to Figure 7 shows that the
content of the FcR+ population in the FsaR tumour remains
constant irrespective of the blood supply proximity; the same
was reported previously for the SCCVII tumour (Olive,
1989).
The final experiments in this study were focused on the
investigation of survival, following PDT in vivo, of tumour
cells located at different distances from the blood supply. In
addition to the administration of the photosensitiser and
Hoechst, the tumours were treated with a light dose of
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Fuge 5 The distribution of protoporphyrin IX and bacterio-
pheophytin-a, formed from the administered ALA and bacterio-
chlorophyll-a, respectively, in SCCVH tumour cells relative to
their proximity to the blood supply. a, ALA (200 mg kg-', i.v.)
administered 2 h before the tumour excision. b, Bacterio-
chlorophyll-a (32 mg kg-', i.p.) administered 24 h before the
tumour excision. Hoechst was ami as described in
Figure 1. Flow cytometry analysis data presentation as in Figure
2. The bars show ± s.d.
10 9 8 7 6 5
Fractions
4' 3 2 1
Fge 6 The distribution of Photofrin in cells of SCCVII (V)
and FsaR (O) tumours relative to their proximity to the blood
supply. Photofrin (25 mg kg-', i.v.) was adminis 24 h before
tumour excision. The data given in the main graph were obtained
with tumours measuring 200-300 mg wet weight (as was the case
in the previous figures). The insert shows the representative
examples of two FsaR tumours of different size. The wet weight
measured 19 mg and 241 mg for the 'snall' and 'large' tumour
respectively. Hoechst administration and flow cytometry analysis
was as in the previous figures. The bars show ± s.d.
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blood supply. The administration of Photofrin and Hoechst was
as described in Figures 6 and I respectively. Before flow
cytometry, the cells were stained for the Fc receptor as described
in the Materials and methods section. The insert shows the
content of FcR-positive cells in individual Hoechst fractions. The
bars are ± s.e. (main graph) or ± s.d. (insert).
80 Jcm2 and they were excised immediately after the ter-
mination of the light treatment. The object of excising
immediately after PDT was to assess the direct killing effect
on tumour cells without the complicating influence of
vascular-mediated cell killing, which has an increasingly
greater contribution with the time the tumour is left in situ.
The cells from different Hoechst fractions were sorted by
flow cytometry and plated for the colony formation. The
results with Photofrin are shown in Figure 8a. The survival
of cells located closer to the tumour blood supply (fractions
10, 9 and 7) was 3-4 times lower than the survival of cells
that are most remote from the vasculature. It should be
noted that the survival data were normalised for the plating
efficiency (PE) of control cells for each of the fractions
obtained from the non-treated tumour. The PEs ranged
typically between 15 and 30%; within the same tumour the
highest PE were in fraction 7, and those for fractions 10 and
I were lower by 5-10%. The data for the treatment with
light only (no Photofrin), which are also included in Figure
8a, confirm that in this case there was no effect on cell
survival. The colony formation of cells from the tumours
with Photofrin not exposed to the light treatment was also
not different from the controls (not shown).
The same type of experiment was performed with two
other photosensitisers (Figure 8b). With AlPcS2, which is
known to be more effective than Photofrin in direct tumour
cell killing by PDT (Henderson & Farrell, 1989), the tumour
cells nearest to the vasculature also showed the lowest sur-
vival. Tumour cell killing decreased steadily with the increase
in the distance of the cells from the blood supply, showing an
aproximately 6-fold difference in survival between the cells of
fractions 1 and 10. In contrast, the results with BPD indicate
only a very limited decrease in the survival of tumour cells
following PDT. The survival level of tumour cells ranged
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Figwe 8 The survival of SCCVII tumour cells following PDT in
vivo depending on their proximity to the blood supply. Hoechst
(37.5 mg kgI, i.v.) was administered 30 min before the light
treatment (80 J cm-). The tumours were excised immediately
after the termination of the light treatment. Known numbers of
tumour cells from Hoechst fractions 1, 4, 7, 9 and 10 and
unsorted cells were plated for the colony formation assay. a, The
survival of cells following Photofrin-based PDT (V) (the
photosensitiser administered as described in Figure 6), with the
data for the light treatment only (A) (no Photofrin) also shown.
b, The survival of ceUs following AlPcS2- (V) or BPD (A)-based
PDT. The administration of AlPcS2 (l0mgkg-', i.v.) was at
24 h before the light treatment, while BPD (2.5 mg kg-', i.v.) was
given to mice 3 h before the light treatment. The bars are s.d.
around 80% and showed no change in relation to their
proximity to the blood supply. In all the experiments present-
ed in Figure 8 the cell yield per gram of tumour tissue was
the same as the control. The PDT treatments of SCCVII
tumour shown in Figure 8 (including those with BPD) were
equieffective in tumour controL resulting in 15-20% tumour
cures (not shown).
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The results presented demonstrate that there are substantial
differences among photosensitisers in their potential to reach
tumour cells distant from the vasculature. Among the
photosensitisers tested, the best properties in this respect were
exhibited by BPD, which showed no decrease in the cellular
content even in the tumour cells most remote from the blood
supply. This is the attribute that would be desirable for
achieving a high level of direct k-illing of tumour cells by
PDT. With respect to this quality, the other photosensitiers
examined followed BPD in this decreasing order: ALA>
AlPcS2/AlPcS4>TPPS2/TPPS4>Photofrin>bacteriochloro-
phyll-a. The uniformity of BPD distribution among the ten
Hoechst fractions presumably reflects good penetration of
this drug from the circulation into the cells that are most
distant from the vasculature. The diffusion potential seen
with different photosensitisers was not paralleled by the
degree of their lipophilicity. This also implies that the affinity
of photosensitisers for binding to specific classes of plasma
proteins (lipoproteins or albumin) (Kessel, 1986) is not a
decisive factor. The results with di- and tetrasulphonated
forms of aluminium phthalocyanine and tetraphenylporphine
showing no significant differences in the distribution pattern
between the ten Hoechst fractions support this suggestion.
It should be noted that AlPcS4 and TPPS4 have been
reported to localise preferentially in the acellular tumour
structures, while AlPcS2 and TPPS2 are retained more selec-
tively in tumour cells (Peng et al., 1990). The observation in
this study that there is very little, if any, difference in cellular
accumulation between di- and tetrasulphonated forms of
these photosensitisers is not contradictory to this finding; the
levels ofAlPcS4 and TPPS4 in the acellular tumour structures
were not measured in this work and they may be much
higher than those in the tumour cellular compartment.
The data shown in this work further indicate that the
photosensitiser property to reach tumour cells removed from
the vasculature is not dependent on tumour type (SCCVII vs
FsaR tumour, Figure 6), tumour size (Figure 6), the route of
the administration (i.p. vs i.v., Figure 2), the time after
administration (Figure 4) or on the characteristics of host cell
infiltrate in the tumour (Figure 7). This leaves the possibility
that a certain property of the photosensitiser molecule not
identified at present is relevant in this respect. The data with
ALA may suggest that this small molecule penetrates well
into regions removed from the vasculature, but the cells that
are the most distant from the blood supply may be too
compromised metabolically to efficiently synthesise protopor-
phyrin IX.
The examination of the survival of SCCVII tumour cells
located at different distances from the blood supply following
the PDT treatment in vivo demonstrates that the direct killing
effect of PDT depends on the blood vessel proximity of
target cells. The examples with Photofrin- and AlPcS2-based
PDT (Figure 8) show that the greatest killing effect was
inflicted on the tumour cells nearest to the vasculature, while
cell survival increased with increased distance from the
nearest blood vessel. Such a response to PDT may reflect
variations in tumour cellular levels of both photosensitiser
and oxygen. Earlier studies with several mouse tumour
models have demonstrated the existence of radiobiological
anoxia in Hoechst fractions most distant from the blood
supply (Chaplin et al., 1985, 1987). However, the decrease in
tumour cell killing with AlPcS-based PDT was already evi-
dent in the fractions relatively close to the vasculature which
have not shown a decline in the photosensitiser level and are
well oxygenated in the non-treated tumour. This may
indicate that a reduction in the oxygen supply was induced in
these cells during the photodynamic light treatment, a
phenomenon suggested by Henderson and Fingar (1989).
Strategies of adjuvant treatments to be combined with PDT,
which would improve tumour oxygenation during the light
irradiation, should allow a greater killing effect at least in
these intermediate regions that exhibit sufficiently high cel-
lular levels of AlPcS,.
The relevance of photosensitiser diffusion potential, once it
has penetrated the tumour vascular lining, is thus clearly
established in this study. The example with BPD, which
shows an optimal diffusion quality but exhibits a poor direct
cytotoxic effect, demonstrates that both these properties are
prerequisites for an ideal photosensitiser. However, the excel-
lent diffusion property of BPD may still contribute to the
efficacy of this photosensitiser in tumour eradication based
on the indirect effects of PDT.
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